NEW YORK, May 14, 2020 (GLOBE NEWSWIRE) — Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced that Sharon Mates, Ph.D., Chief Executive Officer and Chairman, is scheduled to present at the 2020 RBC Capital Markets Global Healthcare Conference. The presentation is scheduled for Tuesday, May 19, 2020 at 9:10 am ET.About Intra-Cellular TherapiesIntra-Cellular Therapies is a biopharmaceutical company founded on Nobel prize-winning research that allows us to understand how therapies affect the inner-workings of cells in the body. The company leverages this intracellular approach to develop innovative treatments for people living with complex psychiatric and neurologic diseases. For more information, please visit www.intracellulartherapies.com.ContactIntra-Cellular Therapies, Inc.
Juan Sanchez, M.D.
Vice President, Corporate Communications and Investor Relations
646-440-9333Burns McClellan, Inc.
Lisa Burns
[email protected]
212-213-0006MEDIA INQUIRIES:Ana Fullmer
Corporate Media Relations W2Owcg
[email protected]
202-507-0130Source: Intra-Cellular Therapies Inc.
Bay Street News